Davis R M Inc. Has $253,000 Stake in DENTSPLY SIRONA Inc. (XRAY)

Davis R M Inc. continued to hold its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,900 shares of the medical instruments supplier’s stock at the end of the second quarter. Davis R M Inc.’s holdings in DENTSPLY SIRONA were worth $253,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Teachers Advisors LLC boosted its position in shares of DENTSPLY SIRONA by 18.5% in the fourth quarter. Teachers Advisors LLC now owns 323,176 shares of the medical instruments supplier’s stock worth $18,657,000 after buying an additional 50,432 shares during the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in shares of DENTSPLY SIRONA by 1.5% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 202,398 shares of the medical instruments supplier’s stock worth $12,638,000 after buying an additional 2,992 shares during the last quarter. Fulton Bank N.A. boosted its position in shares of DENTSPLY SIRONA by 23.8% in the first quarter. Fulton Bank N.A. now owns 5,100 shares of the medical instruments supplier’s stock worth $318,000 after buying an additional 979 shares during the last quarter. Raymond James Trust N.A. boosted its position in shares of DENTSPLY SIRONA by 11.7% in the first quarter. Raymond James Trust N.A. now owns 6,031 shares of the medical instruments supplier’s stock worth $377,000 after buying an additional 630 shares during the last quarter. Finally, Creative Planning boosted its position in shares of DENTSPLY SIRONA by 1.0% in the first quarter. Creative Planning now owns 6,800 shares of the medical instruments supplier’s stock worth $425,000 after buying an additional 70 shares during the last quarter. 95.13% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded down 0.60% during midday trading on Friday, reaching $52.85. 1,573,864 shares of the company traded hands. The company has a 50 day moving average of $61.35 and a 200-day moving average of $62.19. DENTSPLY SIRONA Inc. has a 12-month low of $52.73 and a 12-month high of $65.68. The stock’s market capitalization is $12.13 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The business had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. DENTSPLY SIRONA’s revenue was down 2.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.76 earnings per share. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post $2.69 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Investors of record on Friday, September 29th will be paid a dividend of $0.0875 per share. This represents a $0.35 annualized dividend and a yield of 0.66%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -10.09%.

COPYRIGHT VIOLATION NOTICE: This story was first published by BNB Daily and is owned by of BNB Daily. If you are reading this story on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/19/davis-r-m-inc-holds-position-in-dentsply-sirona-inc-xray-updated.html.

XRAY has been the topic of a number of recent research reports. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating and set a $71.00 price objective on the stock in a research note on Tuesday, May 2nd. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and reduced their price target for the stock from $60.00 to $55.00 in a research report on Tuesday, May 23rd. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. BidaskClub cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, June 10th. Finally, HC Wainwright began coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $66.25.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply